8h30
|
Registration and welcome coffee
|
|
| |
|
|
| |
|
|
Juan Carlos Gaona H. | Chairman of the Board of Directors, INTERFARMA.
|
| |
9h30
|
OFFICIAL OPENING CEREMONY
|
|
| |
|
|
Davi Samuel Alcolumbre Tobelem | President of the Brazilian Federal Senate.
|
| |
| |
Rodrigo Maia | President of the Brazilian Chamber of Deputies.
|
| |
| |
Luiz Henrique Mandetta | Brazilian Minister of Health.
|
| |
| |
| |
ECONOMIC PANEL
|
| |
| |
Caio Megale | Secretary for Development of Industry, Commerce, Services and Innovation of the Brazilian Ministry of Economy.
|
| |
11h
|
CLINICAL TRIALS PANEL
|
|
| |
|
|
Study of INTERFARMA: Clinical Trials and the Global Market
Sydney Clark | Senior Vice President for Global Services and Latin America, IQVIA.
|
| |
| |
R&D in Clinical Pharmacology: a difficult mission but not impossible
Manfredo C. Cozzi | MD and ex-president of Argentine Chamber of Medicinal Specialties (CAEMe).
|
| |
| |
Federal Deputy Hiran Gonçalves | Rapporteur for draft bill on clinical trials (7082/17).
|
| |
| |
Federal Deputy Carmen Zanotto | President, Mixed Parliamentary Health Commission.
|
| |
| |
Moderator: Fábio Franke | President, Brazil Clinical Trial Alliance. |
| |
|
|
| |
|
| |
|
|
Julio Francisco Semeghini Neto | Executive Secretary for Science, Technology, Innovation and Communications of the Brazilian Ministry of Science, Technology, Innovation and Communication.
|
| |
| |
Bernard Munos | CEO, InnoThink Center for Research in Biomedical Innovation, professor at the Stanford Graduate School of Business (USA).
|
| |
| |
Federico De Masi | Senior Bioinformatics Project Manager at Intomics A/S (Denmark).
|
| |
| |
Cláudio Vilar Furtado | President, Brazilian Institute of Industrial Property.
|
| |
| |
Alessandra Bastos | Director, Brazilian Health Surveillance Agency.
|
| |
| |
Moderator: Fernanda De Negri | Researcher, Brazilian Institute of Applied Economic Research and PhD in economics from Campinas State University (Brazil).
|
| |
|
| |
| |
Pharma Outlook 2030 | KPMG
Roger van den Heuvel | Principal, Global Life Sciences sector Lead, Strategy (KPMG).
|
| |
| |
Challenges and Opportunities in Expanding Access to Healthcare in Brazil
Denizar Vianna de Araújo | Secretary, Brazilian Ministry of Health Secretariat of Science, Technology, and Strategic Inputs.
|
| |
| |
Leandro Fonseca da Silva | President, Brazilian Agency for Supplementary Health.
|
| |
| |
Tiago Farina Matos | Legal Director and Advocacy, Oncoguia Institute (ONG).
|
| |
| |
Moderator: Pedro Bernardo | Access and Economics Affairs director, INTERFARMA.
|
| |
|